Filing Details

Accession Number:
0001209191-14-037299
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-28 11:37:29
Reporting Period:
2014-05-23
Filing Date:
2014-05-28
Accepted Time:
2014-05-28 11:37:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130591 Xenoport Inc XNPT Pharmaceutical Preparations (2834) 943330837
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326330 W Ronald Barrett C/O Xenoport, Inc.
3410 Central Expressway
Santa Clara CA 95051
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-23 2,600 $3.75 173,458 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 168,239 Indirect By Trust
Common Stock 1,281 Indirect By Children
Footnotes
  1. The range of prices for this open market purchase transaction is $3.735 to $3.75. Upon request by the SEC staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
  2. The reporting person no longer has a reportable beneficial interest in 833 shares of XNPT common stock owned by his daughter and included in the reporting person's prior ownership reports.